Azimuth Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $490K | Buy |
4,415
+172
| +4% | +$18.2K | 0.02% | 254 |
|
|
2021
Q4 | $439K | Buy |
4,243
+50
| +1% | +$5.79K | 0.02% | 263 |
|
|
2021
Q3 | $526K | Hold |
4,193
| – | – | 0.02% | 254 |
|
|
2021
Q2 | $520K | Buy |
4,193
+28
| +0.7% | +$3.52K | 0.02% | 256 |
|
|
2021
Q1 | $492K | Hold |
4,165
| – | – | 0.02% | 256 |
|
|
2020
Q4 | $488K | Buy |
4,165
+250
| +6% | +$27.5K | 0.02% | 247 |
|
|
2020
Q3 | $407K | Sell |
3,915
-100
| -2% | -$10K | 0.02% | 236 |
|
|
2020
Q2 | $368K | Hold |
4,015
| – | – | 0.02% | 238 |
|
|
2020
Q1 | $362K | Hold |
4,015
| – | – | 0.03% | 231 |
|
|
2019
Q4 | $456K | Hold |
4,015
| – | – | 0.03% | 234 |
|
|
2019
Q3 | $436K | Hold |
4,015
| – | – | 0.03% | 234 |
|
|
2019
Q2 | $391K | Sell |
4,015
-34,245
| -90% | -$3.13M | 0.03% | 236 |
|
|
2019
Q1 | $3.48M | Sell |
38,260
-1,595
| -4% | -$143K | 0.23% | 132 |
|
|
2018
Q4 | $3.63M | Sell |
39,855
-2,360
| -6% | -$221K | 0.28% | 119 |
|
|
2018
Q3 | $4.15M | Sell |
42,215
-2,940
| -7% | -$272K | 0.28% | 122 |
|
|
2018
Q2 | $3.87M | Sell |
45,155
-16,392
| -27% | -$1.37M | 0.28% | 121 |
|
|
2018
Q1 | $4.94M | Sell |
61,547
-10
| -0% | -$825 | 0.36% | 97 |
|
|
2017
Q4 | $4.97M | Buy |
61,557
+2,710
| +5% | +$217K | 0.36% | 100 |
|
|
2017
Q3 | $4.58M | Sell |
58,847
-43,901
| -43% | -$3.64M | 0.34% | 99 |
|
|
2017
Q2 | $9.12M | Sell |
102,748
-838
| -0.8% | -$70.7K | 0.72% | 46 |
|
|
2017
Q1 | $8.35M | Sell |
103,586
-39,472
| -28% | -$3.08M | 0.67% | 48 |
|
|
2016
Q4 | $10.2M | Buy |
143,058
+10,264
| +8% | +$806K | 0.87% | 28 |
|
|
2016
Q3 | $11.5M | Buy |
132,794
+38,184
| +40% | +$3.33M | 1% | 23 |
|
|
2016
Q2 | $8.21M | Buy |
94,610
+4,845
| +5% | +$392K | 0.73% | 45 |
|
|
2016
Q1 | $6.73M | Buy |
89,765
+36,245
| +68% | +$2.73M | 0.64% | 55 |
|
|
2015
Q4 | $4.12M | Buy |
53,520
+1,524
| +3% | +$115K | 0.4% | 89 |
|
|
2015
Q3 | $3.48M | Sell |
51,996
-560
| -1% | -$41.2K | 0.36% | 92 |
|
|
2015
Q2 | $3.89M | Buy |
52,556
+2,028
| +4% | +$155K | 0.38% | 95 |
|
|
2015
Q1 | $3.94M | Buy |
50,528
+2,933
| +6% | +$222K | 0.38% | 92 |
|
|
2014
Q4 | $3.44M | Buy |
47,595
+755
| +2% | +$52.4K | 0.35% | 93 |
|
|
2014
Q3 | $2.9M | Buy |
46,840
+20
| +0% | +$1.27K | 0.32% | 98 |
|
|
2014
Q2 | $2.98M | Buy |
46,820
+730
| +2% | +$44.3K | 0.33% | 100 |
|
|
2014
Q1 | $2.84M | Buy |
46,090
+740
| +2% | +$43.1K | 0.34% | 97 |
|
|
2013
Q4 | $2.6M | Buy |
45,350
+1,050
| +2% | +$59.5K | 0.31% | 111 |
|
|
2013
Q3 | $2.36M | Buy |
44,300
+15,425
| +53% | +$830K | 0.32% | 100 |
|
|
2013
Q2 | $1.49M | Buy |
+28,875
| New | +$1.43M | 0.26% | 119 |
|
Other funds holding MDT
WA
Azimuth Capital Management's MDT Position: Q1 2022 in Review
Azimuth Capital Management increased its Medtronic (MDT) stake by 4.1% in Q1 2022, buying an estimated $18.2K and bringing the position to 4,415 shares worth $490K. The position accounts for 0.02% of the portfolio, ranked #254.
Azimuth Capital Management first reported a position in MDT in Q2 2013 and has held it in 36 quarters since. The position peaked at $11.5M in Q3 2016. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.
- Azimuth Capital Management held 4,415 shares of Medtronic worth $490K as of Q1 2022.
- Azimuth Capital Management bought 172 Medtronic shares in Q1 2022, an estimated $18.2K.
- Medtronic made up 0.02% of Azimuth Capital Management's portfolio in Q1 2022, its #254 holding.
- Azimuth Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 36 quarters since.
- Azimuth Capital Management's Medtronic position peaked at $11.5M in Q3 2016.
- 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.